<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>cancer immunotherapy | Aris Paschalidis</title><link>https://arispas.com/tag/cancer-immunotherapy/</link><atom:link href="https://arispas.com/tag/cancer-immunotherapy/index.xml" rel="self" type="application/rss+xml"/><description>cancer immunotherapy</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Wed, 01 Jan 2025 00:00:00 +0000</lastBuildDate><image><url>https://arispas.com/media/icon_hu11dd96298b64769bb933ab2b7084c44e_12355_512x512_fill_lanczos_center_3.png</url><title>cancer immunotherapy</title><link>https://arispas.com/tag/cancer-immunotherapy/</link></image><item><title>Blocking the PD-1 Signal Transduction by Occupying the Phosphorylated ITSM Recognition Site of SHP-2</title><link>https://arispas.com/publication/li-blocking-pd1-signal-2025/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>https://arispas.com/publication/li-blocking-pd1-signal-2025/</guid><description/></item></channel></rss>